Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości JNJ.US
145.74+0.97(+0.67%)(czas lokalny: 18.04.2024 16:00)Johnson & Johnson
WERSJA BETA
New York Stock Exchange Inc
Biznesradar bez reklam? Sprawdź BR Plus
Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health business last year, the company has been focused […]
The post Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion. The company reported net earnings of $5.3 billion, or $2.20 […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings increased 28% to $4.1 billion and EPS rose […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results first appeared on AlphaStreet.
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has enjoyed an edge over other players in the market due […]
The post Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect first appeared on AlphaStreet.
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical device businesses, on the heels of spinning off […]
The post Johnson & Johnson (JNJ) focuses on innovation after separating consumer business first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales growth was 6.4%. GAAP net earnings remained flat […]
The post JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results first appeared on AlphaStreet.
W każdym dniu bieżącego tygodnia planowane są wystąpienia przedstawicieli amerykańskiego Fedu, w tym w czwartek prezesa J. Powella. Chiny podadzą w środę odczyt PKB za III kw., a w piątek tamtejszy bank centralny podejmie decyzję ws. stóp proc. Rozkręcać się będzie sezon wyników spółek: raporty opublikują m.in. Goldman Sachs, Tesla, J&J i producenci chipów.
After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to release its third-quarter results next week. The company recently announced […]
The post Johnson & Johnson to report earnings on Oct 17. Here’s what to look for first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net earnings rose 6.9% to $5.1 billion while EPS […]
The post Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights first appeared on AlphaStreet.
Ława przysięgłych sądu w Kalifornii orzekła we wtorek, że koncern Johnson&Johnson, gigant na rynku farmaceutycznym, kosmetycznym i medycznym, musi zapłacić mieszkańcowi stanu odszkodowanie w wysokości 18,8 mln dolarów. Firma została oskarżona przez obywatela o to, że zachorował na raka w rezultacie długotrwałego kontaktu z jej zasypką dla dzieci. Koncern zapowiedział odwołanie się od wyroku.
Ława przysięgłych sądu w Kalifornii orzekła we wtorek, że koncern Johnson&Johnson, gigant na rynku farmaceuntycznym, kosmetycznym i medycznym, musi zapłacić odszkodowanie w wysokości 18,8 mln dolarów mieszkańcowi tego stanu, który twierdzi, że zachorował na raka w rezultacie długotrwałego kontaktu z produkowaną przez ten koncern zasypką dla dzieci (baby powder). Koncern zapowiedział odwołanie się od wyroku.
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move is part of the initiatives to rejuvenate the business that […]
The post Earnings Preview: Here’s what to expect from Johnson & Johnson’s Q2 first appeared on AlphaStreet.
J & J Snack Foods Corp (NASDAQ:JJSF) Q2 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Norberto Aja — Investor Relations Dan Fachner — President and Chief Executive Officer Ken Plunk — Chief Financial Officer […]
The post J & J Snack Foods Corp (JJSF) Q2 2023 Earnings Call Transcript first appeared on AlphaStreet.
Biznesradar bez reklam? Sprawdź BR Plus